跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 96 条关于
“Dompé Farmaceutici”
全部
96
临床试验
8
药物
25
机构
38
资讯
25
11个月前
Dompé Receives FDA Priority Voucher for Intranasal NGF Therapy Targeting NAION Vision Loss
6个月前
ARDS Clinical Pipeline Expands with 50+ Companies Developing Novel Therapies
8个月前
Engitix Secures €21 Million Series A Extension to Advance ECM-Targeted Cancer and Fibrosis Therapies
去年
OncoZenge and Molteni Farmaceutici Partner for BupiZenge Commercialization in Europe
9个月前
Dompé Initiates Phase 3 Trial of Dual-Mechanism Isocyclosporin for Atopic Keratoconjunctivitis
5个月前
Dompé Initiates Phase 2 Trial of Intranasal NGF for Spastic Cerebral Palsy in Italy
去年
Chiesi Farmaceutici's Inhaled PI3Kδ Inhibitor Suggests Target Unsuitability for COPD Management
去年
Advancements in Bronchopulmonary Dysplasia Treatment: A Look into the 2024 Pipeline
8年前
NICE Rejects Cenegermin for Rare Eye Disease, Citing Cost Concerns
去年
Palvella Therapeutics Appoints Rare Disease Commercial Expert Ashley Kline as Chief Commercial Officer
第 1 页,共 3 页
上一页
下一页